Fingerprint
Dive into the research topics of 'Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement
Ying C. Henderson, Soon Hyun Ann, Yáan Kang, Gary L. Clayman
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations